SHREE GANESH REMEDIES LIMITEDSHREE GANESH REMEDIES LIMITEDSHREE GANESH REMEDIES LIMITED

SHREE GANESH REMEDIES LIMITED

No trades
See on Supercharts
Market capitalization
‪8.09 B‬INR
‪170.20 M‬INR
‪902.20 M‬INR
‪3.99 M‬
Beta (1Y)
0.20

About SHREE GANESH REMEDIES LIMITED

CEO
Chanudubhai Manubhai Kothia
Headquarters
Ankleshwar
Employees (FY)
110
Founded
1995
ISIN
INE414Y01015
FIGI
BBG00HVHQWR2
Shree Ganesh Remedies Ltd. engages in the research, development, manufacture, and marketing of healthcare products. Its products include intermediate and pharmaceuticals, veterinary products, and bulk drugs. The company was founded on April 27, 1995 and is headquartered in Ankleshwar, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SGRL is 624.95 INR — it has decreased by 0.77% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange SHREE GANESH REMEDIES LIMITED stocks are traded under the ticker SGRL.
SGRL stock is 3.69% volatile and has beta coefficient of 0.20. Check out the list of the most volatile stocks — is SHREE GANESH REMEDIES LIMITED there?
Yes, you can track SHREE GANESH REMEDIES LIMITED financials in yearly and quarterly reports right on TradingView.
SGRL stock has risen by 2.45% compared to the previous week, the month change is a 7.42% fall, over the last year SHREE GANESH REMEDIES LIMITED has showed a 96.62% increase.
SGRL net income for the last quarter is ‪48.01 M‬ INR, while the quarter before that showed ‪65.54 M‬ INR of net income which accounts for −26.74% change. Track more SHREE GANESH REMEDIES LIMITED financial stats to get the full picture.
Yes, SGRL dividends are paid annually. The last dividend per share was 0.50 INR. As of today, Dividend Yield (TTM)% is 0.08%. Tracking SHREE GANESH REMEDIES LIMITED dividends might help you take more informed decisions.
SHREE GANESH REMEDIES LIMITED dividend yield was 0.20% in 2022, and payout ratio reached 3.61%. The year before the numbers were 0.17% and 4.48% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, SGRL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHREE GANESH REMEDIES LIMITED stock right from TradingView charts — choose your broker and connect to your account.
SGRL reached its all-time high on Feb 20, 2024 with the price of 736.00 INR, and its all-time low was 22.05 INR and was reached on Oct 13, 2017.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 110.00 employees. See our rating of the largest employees — is SHREE GANESH REMEDIES LIMITED on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHREE GANESH REMEDIES LIMITED technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHREE GANESH REMEDIES LIMITED stock shows the buy signal. See more of SHREE GANESH REMEDIES LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHREE GANESH REMEDIES LIMITED EBITDA is ‪324.69 M‬ INR, and current EBITDA margin is 27.02%. See more stats in SHREE GANESH REMEDIES LIMITED financial statements.